Emerging treatments for indolent lymphoma.


Non-Hodgkin lymphomas (NHLs) comprise a diverse group of lymphatic malignancies of primarily B-cell origin, which are steadily increasing in prevalence worldwide. Approximately 63,190 new cases of NHL are expected to be diagnosed in the United States in 2007, representing 4% of all cancers. Further, the annual incidence rate of NHL in 2000-2004, estimated… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.